Opyl Limited

Opyl Limited (ASX:OPL)

Offer Price

A$0.0210

per share

Offer Size

A$1,000,000

Open Now!
Apply Now

Placement

Opyl Limited (ASX:OPL)

OPL

Lead Manager

Offer Price

A$0.0210

per share

Offer Size

A$1,000,000

Placement

Opyl Limited

Offer Details

Issue Price (Per Share)

A$0.0210

Discount

19.23%

Offer Size

A$1,000,000

Shares Available

47,619,047

Single Tranche Private Placement Offer utilising the company’s full capacity under Listing Rule 7.1 & 7.1A capacity to raise $1.00mil at $0.021. The offer comes with a 1:2 free attaching unlisted options; exercisable at $0.03 and expiring 4 years from the date of issuance. The issuance of the options will be subject to shareholder approval at an upcoming general meeting.

Documents & Downloads

Company Overview

Opyl Limited (ASX: OPL) is an Australian AI and digital health company at the forefront of the global AI transformation in healthcare. Leveraging cutting-edge artificial intelligence, large language models (LLMs), and advanced platform technology, Opyl’s proprietary platform— TrialKey—optimises clinical trial design, accelerates drug discovery timelines, and reduces development costs. As AI infrastructure, led by platforms such as NVIDIA, fuels a new era of healthcare innovation, Opyl is positioned at the intersection of AI, life sciences, and predictive analytics.

Use Of Funds

The funds raised will be focused towards:

  • TrialKey sales, marketing and support
  • TrialKey development and infrastructure
  • Assessing new opportunities
  • General working capital

Indicative Timetable

OPL placed in Trading Halt

Wednesday, April 30, 2025

Placement Offer Opens

Wednesday, April 30, 2025

Placement Offer Closes

5pm AEST Thursday, May 01, 2025

Offer letters accepted

Thursday, May 01, 2025

OPL Recommences Trading

Friday, May 02, 2025

DVP Settlement of Shares

Friday, May 09, 2025

Allotment of Shares

Monday, May 12, 2025

Board & Management

Saurabh Jain

Saurabh Jain

Executive Chairman

Saurabh Jain’s journey in the technology and business sectors is a testament to his entrepreneurial spirit and deep understanding of how technology can drive organisational change. Starting from humble beginnings as a software developer, Saurabh built a startup that successfully grew to over 2,500 customers before being acquired by Telstra. This initial success set the stage for his extensive career in SaaS commercialisation and senior executive roles, including serving as the CEO and Executive Director of Urbanise, an ASX-listed SaaS company. Alongside his professional achievements, Saurabh holds an undergraduate degree and two master’s degrees, providing a strong foundation for his strategic and innovative approach to business.

Saurabh is deeply passionate about helping organisations leverage technology to implement transformative changes. His board experience spans listed ASX companies, purpose-driven organisations, and private companies, where he brings his expertise in technology, commercialisation, and people management. As the Executive Chairman of Opyl Limited, Saurabh continues to drive the company’s vision of transforming healthcare through advanced digital solutions and artificial intelligence, guiding the organisation in navigating the intersection of technology and business strategy.

Damon Rasheed

Damon Rasheed

Executive Director

Damon Rasheed is a serial entrepreneur and pioneer in the tech industry, recognised for his ventures in machine learning and big data solutions. As the co-founder of several successful companies, including Advantage Data, Aurum Data, Foreshore Data, Rate Detective, iBus Media, and Rankster, Damon has consistently demonstrated his entrepreneurial acumen. His career began with the establishment of internet startups that leveraged big data analysis, showcasing his foresight in emerging technologies. Over the past two decades, he has developed expertise in machine learning, AI, econometrics, financial control, project management, economic consultancy, and digital marketing.

Currently serving as an executive board member of Opyl Limited (ASX: OPL), Damon continues to drive innovation in digital health and AI solutions. He developed TrialKey, an AI-driven clinical trial predictor with over 90% accuracy, aimed at revolutionising clinical trials by refining recommendations and optimising design and investment decisions. Damon's passion for econometrics and machine learning, coupled with his diverse background—including a regulatory stint with the Australian Government in anti-trust and advising successful ICOs like Bankera—positions him as a visionary leader shaping the future of tech and healthcare industries. His work has been featured on ABC radio, A Current Affair, Channel 7 news, and he is a frequent speaker at corporate and industry events.

Antanas Guoga

Antanas Guoga

Non Executive Director

Antanas Guoga, widely known by his nickname ‘Tony G’, is a serial digital entrepreneur and venture capitalist renowned for his investments in start-ups in the digital space. As an entrepreneurship enabler, Antanas has founded, co-founded, and owned companies across Australia, the USA, and Lithuania, employing around 500 people. His ventures operate in emerging technologies such as AI and blockchain, reflecting his deep understanding of the challenges and opportunities in these fields. Antanas is also the founder of the biggest online poker news website, PokerNews.com, which grew into one of the largest online gaming affiliates globally.

Antanas’s distinguished career includes serving as a member of the European Parliament for Lithuania, where he advocated for a better entrepreneurial climate and improved business conditions. He launched the Blockchain Centre in Vilnius, Lithuania, connecting stakeholders across three continents with partner centres in Melbourne and Shanghai. Additionally, he founded CryptoNews.com and has been recognised with numerous awards, including the World Lithuanian of the Year prize in 2011 and inclusion in POLITICO’s influential lists. As a philanthropist, Antanas established his own fund in 2014, donating his European Parliament salary to charity and promoting youth entrepreneurship through events like #SWITCH!, the largest ICT and entrepreneurship event in the Baltic countries. Currently, Antanas serves as a non-executive director at Opyl Limited, contributing his vast expertise to the digital health and AI sectors.

Disclaimer

This site does not constitute an offer, recommendation, or invitation to any person, nor does it purport to provide all of the information an interested party may require in order to investigate the affairs of Opyl Limited. This site is provided for information only and has not been prepared with the intention that the recipient should rely on it. Liquidity Technology Pty Ltd ("Liquidity") does not make any representation in relation to the contents of this site or give any assurances as to the accuracy or the degree of care or diligence used in preparing this document. The information, data, and advice herein is provided to recipients on the clear understanding that Liquidity nor any of its representatives, directors, officers, employees, agents, or advisers makes any representation or warranty about its accuracy, reliability, completeness, or suitability for any particular purpose and does not accept liability (including, but not limited to, for any expenses, losses, damages, and/or costs (including, but not limited to, indirect or consequential damage)) nor take any responsibility of any kind whatsoever (including, but not limited to, whether in contract, tort, financial or otherwise) for the information, data, or advice contained in or for any omission or for any other information, statement, or representation provided to any recipient (including, but not limited to, as a result of information, data, or advice being inaccurate, unreliable, incomplete, or unsuitable in any way and for any reason whatsoever). Users of this site must conduct their own investigation and analysis regarding any information, statement, or representation contained or provided to any recipient or its associates by Liquidity or any of the Liquidity Personnel. Each recipient waives any right of action, which it has now or in the future against Liquidity or any of the Liquidity Personnel in respect of any errors or omissions on or from this site, however caused. All rights are reserved. If the whole or any part of a provision of this "Notice and Disclaimer" is invalid, illegal, or unenforceable, then such provision will be severed and neither that part or provision or its severance will affect the validity or enforceability of the remaining parts or provisions.

Disclosure of Interest: Liquidity receives commission from dealing in securities and its introducers of business may directly share in this commission. Liquidity and its associates may hold shares in Opyl Limited.

Opyl Limited

Placement

Opyl Limited (ASX:OPL)

OPL

Offer Price

A$0.0210

per share

Offer Size

A$1,000,000

Cancel

I am a sophisticated 708 investor and agree to the terms and conditions

Opyl Limited

Follow Opyl Limited

By submitting your information below you can keep up to date with their relevant news and announcements.

Fields marked with * are required.

Name(Required)

Cancel

Opyl Limited

Ask Opyl Limited a question

Ask the company directors a question to understand more about their offering.

Fields marked with * are required.

Name(Required)

Cancel

Opyl Limited

Submit your details below to get access to the product documents and invest.

Cancel